Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1221

1.

Leg restlessness preceding the onset of motor symptoms of Parkinson disease: A case series of 5 patients.

Suzuki K, Fujita H, Watanabe Y, Matsubara T, Kadowaki T, Sakuramoto H, Hamaguchi M, Nozawa N, Hirata K.

Medicine (Baltimore). 2019 Aug;98(33):e16892. doi: 10.1097/MD.0000000000016892.

2.

The association between health literacy levels and patient-reported outcomes in Japanese type 2 diabetic patients.

Ueno H, Ishikawa H, Suzuki R, Izumida Y, Ohashi Y, Yamauchi T, Kadowaki T, Kiuchi T.

SAGE Open Med. 2019 Jul 23;7:2050312119865647. doi: 10.1177/2050312119865647. eCollection 2019.

3.

Autosomal dominant Hashimoto's thyroiditis with a mutation in TNFAIP3.

Hori T, Ohnishi H, Kadowaki T, Kawamoto N, Matsumoto H, Ohara O, Fukao T.

Clin Pediatr Endocrinol. 2019;28(3):91-96. doi: 10.1297/cpe.28.91. Epub 2019 Jul 20.

4.

Carotid Intima-Media Thickness and Plaque in Apparently Healthy Japanese Individuals with an Estimated 10-Year Absolute Risk of CAD Death According to the Japan Atherosclerosis Society (JAS) Guidelines 2012: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).

Kadota A, Miura K, Okamura T, Fujiyoshi A, Ohkubo T, Kadowaki T, Takashima N, Hisamatsu T, Nakamura Y, Kasagi F, Maegawa H, Kashiwagi A, Ueshima H; SESSA Research Group and for the NIPPON DATA80/90 Research Group.

J Atheroscler Thromb. 2019 Aug 1;26(8):746. doi: 10.5551/jat.ER17244. Epub 2019 Jul 19. No abstract available.

5.

Diabetes care providers' manual for disaster diabetes care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

Diabetol Int. 2019 Jun 14;10(3):153-179. doi: 10.1007/s13340-019-00397-7. eCollection 2019 Jul.

PMID:
31275782
7.

Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector.

Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, Natsumoto B, Fujio K, Kumaki E, Okano T, Ono S, Tanita K, Morio T, Kanegane H, Hasegawa H, Mizoguchi F, Kawahata K, Kohsaka H, Moritake H, Nunoi H, Waki H, Tamaru SI, Sasako T, Yamauchi T, Kadowaki T, Tanaka H, Kitanaka S, Nishimura K, Ohtaka M, Nakanishi M, Otsu M.

Stem Cell Res Ther. 2019 Jun 24;10(1):185. doi: 10.1186/s13287-019-1273-2.

8.

Variation in process quality measures of diabetes care by region and institution in Japan during 2015-2016: An observational study of nationwide claims data.

Sugiyama T, Imai K, Ihana-Sugiyama N, Tanaka H, Yanagisawa-Sugita A, Sasako T, Higashi T, Okamura T, Yamauchi T, Ueki K, Ohsugi M, Kadowaki T.

Diabetes Res Clin Pract. 2019 Jun 20:107750. doi: 10.1016/j.diabres.2019.05.029. [Epub ahead of print]

9.

Diabetes Care Providers' Manual for Disaster Diabetes Care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

J Diabetes Investig. 2019 Jul;10(4):1118-1142. doi: 10.1111/jdi.13053. Epub 2019 Jun 14.

10.

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.

Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M, Pedersen KB, Saugstrup T, Meier JJ; PIONEER 4 investigators.

Lancet. 2019 Jul 6;394(10192):39-50. doi: 10.1016/S0140-6736(19)31271-1. Epub 2019 Jun 8. Erratum in: Lancet. 2019 Jul 6;394(10192):e1.

PMID:
31186120
11.

Honey Bee Parasitic Mite Contains the Sensilla-Rich Sensory Organ on the Foreleg Tarsus Expressing Ionotropic Receptors With Conserved Functions.

Lei J, Liu Q, Kadowaki T.

Front Physiol. 2019 May 9;10:556. doi: 10.3389/fphys.2019.00556. eCollection 2019.

12.

Biocomputational Analyses and Experimental Validation Identify the Regulon Controlled by the Redox-Responsive Transcription Factor RpaB.

Riediger M, Kadowaki T, Nagayama R, Georg J, Hihara Y, Hess WR.

iScience. 2019 May 31;15:316-331. doi: 10.1016/j.isci.2019.04.033. Epub 2019 Apr 28.

13.

Gene Disruption of Honey Bee Trypanosomatid Parasite, Lotmaria passim, by CRISPR/Cas9 System.

Liu Q, Lei J, Kadowaki T.

Front Cell Infect Microbiol. 2019 Apr 26;9:126. doi: 10.3389/fcimb.2019.00126. eCollection 2019.

14.

Usage Patterns of GlucoNote, a Self-Management Smartphone App, Based on ResearchKit for Patients With Type 2 Diabetes and Prediabetes.

Yamaguchi S, Waki K, Nannya Y, Nangaku M, Kadowaki T, Ohe K.

JMIR Mhealth Uhealth. 2019 Apr 24;7(4):e13204. doi: 10.2196/13204.

15.

Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.

Wakabayashi T, Yamaguchi K, Matsui K, Sano T, Kubota T, Hashimoto T, Mano A, Yamada K, Matsuo Y, Kubota N, Kadowaki T, Iwatsubo T.

Mol Neurodegener. 2019 Apr 12;14(1):15. doi: 10.1186/s13024-019-0315-7.

16.

Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials.

Rose L, Kadowaki T, Pieber TR, Buchholtz K, Ekelund M, Gorst-Rasmussen A, Philis-Tsimikas A.

Diabetes Ther. 2019 Jun;10(3):1029-1041. doi: 10.1007/s13300-019-0608-4. Epub 2019 Apr 4.

17.

NAD+ supplementation rejuvenates aged gut adult stem cells.

Igarashi M, Miura M, Williams E, Jaksch F, Kadowaki T, Yamauchi T, Guarente L.

Aging Cell. 2019 Jun;18(3):e12935. doi: 10.1111/acel.12935. Epub 2019 Mar 27.

18.

Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.

Saheki T, Moriyama M, Kuroda E, Funahashi A, Yasuda I, Setogawa Y, Gao Q, Ushikai M, Furuie S, Yamamura KI, Takano K, Nakamura Y, Eto K, Kadowaki T, Sinasac DS, Furukawa T, Horiuchi M, Tai YH.

Sci Rep. 2019 Mar 12;9(1):4179. doi: 10.1038/s41598-019-39627-y.

19.

An interpretable machine learning model for diagnosis of Alzheimer's disease.

Das D, Ito J, Kadowaki T, Tsuda K.

PeerJ. 2019 Mar 1;7:e6543. doi: 10.7717/peerj.6543. eCollection 2019.

20.

KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1.

Narahara S, Sakai E, Kadowaki T, Yamaguchi Y, Narahara H, Okamoto K, Asahina I, Tsukuba T.

Sci Rep. 2019 Mar 5;9(1):3523. doi: 10.1038/s41598-019-40240-2.

21.

Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism.

Sasako T, Ohsugi M, Kubota N, Itoh S, Okazaki Y, Terai A, Kubota T, Yamashita S, Nakatsukasa K, Kamura T, Iwayama K, Tokuyama K, Kiyonari H, Furuta Y, Shibahara J, Fukayama M, Enooku K, Okushin K, Tsutsumi T, Tateishi R, Tobe K, Asahara H, Koike K, Kadowaki T, Ueki K.

Nat Commun. 2019 Feb 27;10(1):947. doi: 10.1038/s41467-019-08591-6.

22.

Societal Marketing in the Treatment of Type 2 Diabetes Mellitus: A Longitudinal Questionnaire Survey for Michelin-Starred Restaurants in Japan.

Yamada S, Yamada Y, Irie J, Hara K, Kadowaki T, Atsumi Y.

Int J Environ Res Public Health. 2019 Feb 21;16(4). pii: E636. doi: 10.3390/ijerph16040636.

23.

Differences Between Patient-Reported Versus Clinician-Observed Nonulcerative Signs and Symptoms of the Foot in Patients With Diabetes Mellitus.

Takehara K, Oe M, Ohashi Y, Tsunemi Y, Kadowaki T, Sanada H.

J Wound Ostomy Continence Nurs. 2019 Mar/Apr;46(2):113-116. doi: 10.1097/WON.0000000000000504.

PMID:
30747799
24.

Extended Posterior Leaflet Augmentation for Ischemic Mitral Regurgitation - Augmented Posterior Leaflet Snuggling up to Anterior Leaflet.

Ikeda N, Yamaguchi H, Takagaki M, Mitsuyama S, Ebato M, Tanno K, Nakamura H, Kadowaki T, Ueno Y, Kataoka H, Uchida T, Aoki T.

Circ J. 2019 Feb 25;83(3):567-575. doi: 10.1253/circj.CJ-18-0849. Epub 2019 Feb 9.

25.

Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.

Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, Hozawa A, Kadota A, Kuriki K, Naito M, Tanno K, Ishigaki Y, Hirata M, Matsuda K, Iwata N, Ikeda M, Sawada N, Yamaji T, Iwasaki M, Ikegawa S, Maeda S, Murakami Y, Wakai K, Tsugane S, Sasaki M, Yamamoto M, Okada Y, Kubo M, Kamatani Y, Horikoshi M, Yamauchi T, Kadowaki T.

Nat Genet. 2019 Mar;51(3):379-386. doi: 10.1038/s41588-018-0332-4. Epub 2019 Feb 4.

PMID:
30718926
26.

Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune encephalomyelitis.

Wimmer I, Scharler C, Zrzavy T, Kadowaki T, Mödlagl V, Rojc K, Tröscher AR, Kitic M, Ueda S, Bradl M, Lassmann H.

Acta Neuropathol Commun. 2019 Jan 31;7(1):14. doi: 10.1186/s40478-019-0667-9.

27.

Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.

Takanashi M, Kimura T, Li C, Tanaka M, Matsuhashi A, Yoshida H, Noda A, Xu P, Takase S, Okazaki S, Iizuka Y, Kumagai H, Ikeda Y, Gotoda T, Takahashi M, Yagyu H, Ishibashi S, Yamauchi T, Kadowaki T, Liang G, Okazaki H.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):373-386. doi: 10.1161/ATVBAHA.118.311931.

PMID:
30700132
28.

The Gα12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity.

Yanagida K, Igarashi H, Yasuda D, Kobayashi D, Ohto-Nakanishi T, Akahoshi N, Sekiba A, Toyoda T, Ishijima T, Nakai Y, Shojima N, Kubota N, Abe K, Kadowaki T, Ishii S, Shimizu T.

JCI Insight. 2018 Dec 20;3(24). pii: 97293. doi: 10.1172/jci.insight.97293.

29.

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.

Taira M, Imamura M, Takahashi A, Kamatani Y, Yamauchi T, Araki SI, Tanaka N, van Zuydam NR, Ahlqvist E, Toyoda M, Umezono T, Kawai K, Imanishi M, Watada H, Suzuki D, Maegawa H, Babazono T, Kaku K, Kawamori R; SUMMIT Consortium, Groop LC, McCarthy MI, Kadowaki T, Maeda S.

PLoS One. 2018 Dec 19;13(12):e0208654. doi: 10.1371/journal.pone.0208654. eCollection 2018.

30.

Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity.

Kubota T, Inoue M, Kubota N, Takamoto I, Mineyama T, Iwayama K, Tokuyama K, Moroi M, Ueki K, Yamauchi T, Kadowaki T.

Nat Commun. 2018 Nov 19;9(1):4863. doi: 10.1038/s41467-018-07358-9.

31.

Genomes of trombidid mites reveal novel predicted allergens and laterally transferred genes associated with secondary metabolism.

Dong X, Chaisiri K, Xia D, Armstrong SD, Fang Y, Donnelly MJ, Kadowaki T, McGarry JW, Darby AC, Makepeace BL.

Gigascience. 2018 Dec 1;7(12). doi: 10.1093/gigascience/giy127.

32.

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME® trial.

Kadowaki T, Nangaku M, Hantel S, Okamura T, von Eynatten M, Wanner C, Koitka-Weber A.

J Diabetes Investig. 2019 May;10(3):760-770. doi: 10.1111/jdi.12971. Epub 2019 Jan 7.

33.

Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity.

Okada-Iwabu M, Iwabu M, Yamauchi T, Kadowaki T.

Endocr J. 2018 Oct 29;65(10):971-977. doi: 10.1507/endocrj.EJ18-0310. Epub 2018 Oct 3. Review.

34.

Long-standing persistent effects of atrial volume reduction combined with pulmonary vein isolation.

Takagaki M, Ikeda N, Yamaguchi H, Mitsuyama S, Kadowaki T, Nakao T.

J Cardiol Cases. 2018 Jun 18;18(3):99-102. doi: 10.1016/j.jccase.2018.05.011. eCollection 2018 Sep.

35.

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.

Buse JB, Carlson AL, Komatsu M, Mosenzon O, Rose L, Liang B, Buchholtz K, Horio H, Kadowaki T.

Diabetes Obes Metab. 2018 Dec;20(12):2885-2893. doi: 10.1111/dom.13545. Epub 2018 Oct 10.

36.

Corrigendum to "Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population." [Atherosclerosis 246 (March 2016) 141-147].

Ueshima H, Kadowaki T, Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Sekikawa A, Kadota A, Kadowaki S, Nakamura Y, Miyagawa N, Okamura T, Kita Y, Takashima N, Kashiwagi A, Maegawa H, Horie M, Yamamoto T, Kimura T, Kita T; ACCESS and SESSA Research Groups.

Atherosclerosis. 2018 Nov;278:336. doi: 10.1016/j.atherosclerosis.2018.07.039. Epub 2018 Aug 27. No abstract available.

PMID:
30166205
37.

Correction: Por Secretion System-Dependent Secretion and Glycosylation of Porphyromonas gingivalis Hemin-Binding Protein 35.

Shoji M, Sato K, Yukitake H, Kondo Y, Narita Y, Kadowaki T, Naito M, Nakayama K.

PLoS One. 2018 Aug 29;13(8):e0203154. doi: 10.1371/journal.pone.0203154. eCollection 2018.

38.

Post-cardiotomy venovenous extracorporeal membrane oxygenation without heparinization.

Takagaki M, Yamaguchi H, Ikeda N, Takeda K, Kasai F, Yahagi K, Kanzaki S, Mitsuyama S, Kadowaki T, Kotani T.

Gen Thorac Cardiovasc Surg. 2018 Aug 17. doi: 10.1007/s11748-018-0990-2. [Epub ahead of print]

PMID:
30120673
39.

Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics and severity of renal impairment: A Japanese database analysis.

Kadowaki T, Sarai N, Hirakawa T, Taki K, Iwasaki K, Urushihara H.

Diabetes Obes Metab. 2018 Dec;20(12):2830-2839. doi: 10.1111/dom.13463. Epub 2018 Aug 2.

40.

Author Correction: Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice.

Liu Y, Wu Z, Nakanishi Y, Ni J, Hayashi Y, Takayama F, Zhou Y, Kadowaki T, Nakanishi H.

Sci Rep. 2018 Jul 4;8(1):10304. doi: 10.1038/s41598-018-27508-9.

41.

The RNA Methyltransferase Complex of WTAP, METTL3, and METTL14 Regulates Mitotic Clonal Expansion in Adipogenesis.

Kobayashi M, Ohsugi M, Sasako T, Awazawa M, Umehara T, Iwane A, Kobayashi N, Okazaki Y, Kubota N, Suzuki R, Waki H, Horiuchi K, Hamakubo T, Kodama T, Aoe S, Tobe K, Kadowaki T, Ueki K.

Mol Cell Biol. 2018 Jul 30;38(16). pii: e00116-18. doi: 10.1128/MCB.00116-18. Print 2018 Aug 15.

42.

Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.

Kadowaki T, Haneda M, Ito H, Sasaki K, Hiraide S, Matsukawa M, Ueno M.

Adv Ther. 2018 Jun;35(6):817-831. doi: 10.1007/s12325-018-0704-2. Epub 2018 May 17.

43.

Effect of short-term treatment with sitagliptin or glibenclamide on daily glucose fluctuation in drug-naïve Japanese patients with type 2 diabetes mellitus.

Suzuki R, Eiki JI, Moritoyo T, Furihata K, Wakana A, Ohta Y, Tokita S, Kadowaki T.

Diabetes Obes Metab. 2018 Sep;20(9):2274-2281. doi: 10.1111/dom.13364. Epub 2018 Jun 11.

PMID:
29770541
44.

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.

Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K.

J Gastroenterol. 2018 Dec;53(12):1261-1275. doi: 10.1007/s00535-018-1472-0. Epub 2018 May 10.

45.

International Comparison of Abdominal Fat Distribution Among Four Populations: The ERA-JUMP Study.

Kadowaki S, Miura K, Kadowaki T, Fujiyoshi A, El-Saed A, Masaki KH, Okamura T, Edmundowicz D, Rodriguez BL, Nakamura Y, Barinas-Mitchell EJM, Kadota A, Willcox BJ, Abbott RD, Kuller LH, Choo J, Shin C, Ueshima H, Sekikawa A; ERA JUMP Study Group.

Metab Syndr Relat Disord. 2018 May;16(4):166-173. doi: 10.1089/met.2017.0132.

46.

Interaction of the GntR-family transcription factor Sll1961 with thioredoxin in the cyanobacterium Synechocystis sp. PCC 6803.

Kujirai J, Nanba S, Kadowaki T, Oka Y, Nishiyama Y, Hayashi Y, Arai M, Hihara Y.

Sci Rep. 2018 Apr 27;8(1):6666. doi: 10.1038/s41598-018-25077-5.

47.

Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.

Haneda M, Kadowaki T, Ito H, Sasaki K, Hiraide S, Ishii M, Matsukawa M, Ueno M.

Diabetes Ther. 2018 Jun;9(3):1083-1097. doi: 10.1007/s13300-018-0416-2. Epub 2018 Apr 10.

48.

Biosimilar vs originator insulins: Systematic review and meta-analysis.

Yamada T, Kamata R, Ishinohachi K, Shojima N, Ananiadou S, Nom H, Yamauchi T, Kadowaki T.

Diabetes Obes Metab. 2018 Jul;20(7):1787-1792. doi: 10.1111/dom.13291. Epub 2018 Apr 17.

PMID:
29536603
49.

Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials.

Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T.

Diabetes Obes Metab. 2018 Jul;20(7):1755-1761. doi: 10.1111/dom.13260. Epub 2018 Mar 25.

PMID:
29451721
50.

Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis.

Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T.

Diabetes Care. 2018 Apr;41(4):e52-e55. doi: 10.2337/dc17-2095. Epub 2018 Feb 15. No abstract available.

PMID:
29449311

Supplemental Content

Loading ...
Support Center